MoneyWorks4Me

Hester Biosciences informs about board meeting

27 Oct 2023 Evaluate
Hester Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended 30 September 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1861.20
Dr. Reddys Labs. 1214.10
Cipla 1374.60
Lupin 2096.50
Zydus Lifesciences 1159.65
View more..